Clinical trial
A Randomized Controlled Trial of Atrioventricular (AV) Junction Ablation and Biventricular Pacing Versus Optimal Pharmacological Therapy in Patients With Permanent Atrial Fibrillation
NCT02137187 is registered in ClinicalTrials.gov with Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Atrioventricular (AV) Junction Ablation and Biventricular Pacing Versus Optimal Pharmacological Therapy in Patients With Permanent Atrial Fibrillation
- Lead sponsor
- Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 15, 2014
- Completion date
- July 31, 2021
- Enrollment
- 1,830 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
permanent atrial fibrillation